Report Delivers ROI Analysis for Key Lifecycle Management Strategies Utilized by the Pharmaceutical Industry
CHAPEL HILL, N.C. – February 24, 2012. With fewer products in the pipeline and more at the edge of the patent cliff, strategies to extend the commercial life of mature brands are critical to today's pharmaceutical industry. Used correctly, lifecycle management strategies can add as many as 10 years and billions of dollars to the life of an established or mature brand.
To help biopharmaceutical companies more effectively conduct the many activities related to lifecycle management, Best Practices, LLC has published a new study, "Lifecycle Management Excellence: High-Performing Strategies Used to Maximize Potential of Mature Brands."
The report delivers hard-to-find benchmarks around the implementation time, cost and ROI of frequently used lifecycle management strategies. It also provides benchmarks on the optimal size and structure of Mature Brand Organizations, as well as the barriers and regulations affecting the strategies used by Mature Brand Organizations.
Using a list of 20 key lifecycle management strategies, the study delivers insights from mature brand leaders around three critical issues facing each strategy: How long do they take to implement, how much do they cost and how much will they return?
An example of one of the many insights in this study: Benchmark partners believe strategic pricing strategies most often cost less than any of the others probed in the study. Two-thirds who used this strategy found the cost was less than $1 Million compared with only 50 percent for re-positioning, which was the next cheapest strategy. Meanwhile, moving into emerging markets costs over $10 million, according to 40 percent of the participants.
Key report topics include:
- Barriers of Key Lifecycle Management (LCM) Strategies
- Strategies Weakened By Regulation or Reform
- Mature Brand Organizations
- Case Example: Pfizer’s Lipitor
- Success Factors & Lessons Learned
- Corporate Lifecycle Management (LCM) Goals & Policies
- Use of Key LCM Strategies
- Comparative Effectiveness of Key LCM Strategies
- Relative Costs of Key LCM Strategies
- Relative Time of Key LCM Strategies
- ROI of Key LCM Strategies
- Gains from Using LCM Strategies
Research participants included 25 executives and managers from 18 different pharmaceutical and biotech companies
To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1149.htm
For more information on this study or other recent primary research studies, contact us at 919.403.0251 or at email@example.com.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC’s clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.